3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
8
Carcinoma, Non-Small-Cell Lung
8
Glioblastoma
6
Rectal Neoplasms
5
Oropharyngeal Neoplasms
5
Breast Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
4
Lung Neoplasms
4
Burkitt Lymphoma
4
Astrocytoma
4
Urinary Bladder Neoplasms
3
Mouth Neoplasms
3
Glioma
3
Carcinoma, Squamous Cell
3
Adenocarcinoma of Lung
3
Rhabdomyosarcoma
2
Pancreatic Neoplasms
2
Mesothelioma, Malignant
2
Lymphoma, Follicular
2
Laryngeal Neoplasms
2
Hodgkin Disease
2
Esophageal Neoplasms
2
Carcinoma
2
Breast Carcinoma In Situ
2
Adenocarcinoma, Bronchiolo-Alveolar
2
Wilms Tumor
1
Vaginal Neoplasms
1
Uterine Cervical Neoplasms
1
Triple Negative Breast Neoplasms
1
Skin Neoplasms
1
Interventions
fludarabine phosphate
1
Whole-Body Irradiation
1
Tacrolimus
1
Sirolimus
1
Peripheral Blood Stem Cell Transplantation
1
Mycophenolic Acid
1
Methotrexate
1
Melphalan
1
Etoposide
1
Cyclosporine
1
Cyclophosphamide
1
Busulfan
1
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Anemia, Aplastic
×
Radiotherapy
×
30 days
×
Clear all
No trials found.